All Pathways
Hepatobiliary SurgeryEmergency

Acute Variceal Hemorrhage Management (Baveno VII 2022)

Acute Variceal Hemorrhage Management (Baveno VII 2022): Acute Variceal Hemorrhage → Initial Resuscitation → Vasoactive Therapy (START IMMEDIATELY) → Pro...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Acute Variceal Hemorrhage

    Suspected or confirmed variceal bleeding

    1. Warning

      Initial Resuscitation

      SIMULTANEOUS interventions

      • Secure airway (intubate if altered MS/massive)
      • Large bore IV access x 2
      • Type and crossmatch
      • Restrictive transfusion: Target Hgb 7-8 g/dL
      • Avoid over-resuscitation (worsens PHT)
      • Correct coagulopathy if INR >2.5
      • Platelets if <50,000
      1. Action

        Vasoactive Therapy (START IMMEDIATELY)

        Before EGD - reduces portal pressure

        • OCTREOTIDE (US first-line):
        • - Bolus: 50 mcg IV
        • - Infusion: 50 mcg/hr x 2-5 days
        • TERLIPRESSIN (if available):
        • - 2 mg IV q4h x 48h, then 1 mg q4h
        • - Contraindicated in CAD, PVD
        • OR SOMATOSTATIN:
        • - Bolus: 250 mcg IV
        • - Infusion: 250-500 mcg/hr
        1. Action

          Prophylactic Antibiotics

          Reduces mortality - START IMMEDIATELY

          • CEFTRIAXONE 1g IV q24h (preferred)
          • - For 5-7 days
          • - Reduces rebleeding and mortality
          • - Prevents SBP
          • ALTERNATIVE: Norfloxacin 400mg PO BID
          • (if low-risk, no quinolone resistance)
          1. Action

            PPI Therapy

            After banding

            • High-dose PPI after EVL
            • Pantoprazole 40mg IV BID or
            • Omeprazole 40mg IV BID
            • Promotes ulcer healing post-banding
            1. Action

              Urgent EGD

              Within 12 hours of presentation

              • Timing: Within 12 hours
              • After hemodynamic stabilization
              • Intubation if: Massive bleed, encephalopathy
              • Erythromycin 250mg IV 30-90 min before
              • (improves visualization)
              1. Decision

                Endoscopic Findings

                Type of varices

                1. Action

                  Esophageal Varices

                  Band ligation first-line

                  • ENDOSCOPIC VARICEAL LIGATION (EVL)
                  • - First-line therapy
                  • - Multiple bands at bleeding site
                  • - Start distally, move proximally
                  • SCLEROTHERAPY:
                  • - If EVL not possible
                  • - Higher complication rate
                  1. Decision

                    Hemostasis Achieved?

                    Assess for rebleeding

                    1. Warning

                      Rescue Therapy

                      For refractory bleeding

                      • BALLOON TAMPONADE (bridge to TIPS):
                      • - Sengstaken-Blakemore or Minnesota tube
                      • - Inflate gastric balloon first
                      • - Max 24 hours
                      • - Intubate before placement
                      • SELF-EXPANDING METAL STENT:
                      • - Danis/SX-Ella stent
                      • - Alternative to balloon
                      • Then → TIPS
                      1. Action

                        TIPS (Transjugular Intrahepatic Portosystemic Shunt)

                        For refractory/high-risk

                        • INDICATIONS:
                        • - Refractory to endoscopic therapy
                        • - High-risk patients (preemptive TIPS)
                        • EARLY/PREEMPTIVE TIPS:
                        • - Within 72h (ideally <24h)
                        • - For Child-Pugh B with active bleeding
                        • - For Child-Pugh C (10-13 points)
                        • COVERED STENTS preferred
                        • Reduces rebleeding to <15%
                        1. Action

                          Secondary Prophylaxis

                          Prevent rebleeding

                          • NSBB + EVL combination:
                          • - Propranolol: Target HR 55-60
                          • - Or Carvedilol 6.25-12.5mg BID
                          • - Repeat EVL q2-4 weeks until obliterated
                          • If TIPS placed: Annual surveillance
                          • Lifelong therapy required
                          1. Outcome

                            Outcomes

                            Prognosis

                            • 6-week mortality: 15-20%
                            • Rebleeding without prophylaxis: 60%
                            • Rebleeding with NSBB + EVL: 20-30%
                            • TIPS controls bleeding: >90%
                            • Consider transplant evaluation
                2. Action

                  Gastric Varices

                  Cyanoacrylate glue or TIPS

                  • GOV1 (extending from EV): EVL may work
                  • GOV2/IGV1: Cyanoacrylate injection
                  • - 0.5-1 mL per injection
                  • - Mixed with lipiodol
                  • Consider early TIPS for gastric varices

Guideline Source

Baveno VII Consensus for Portal Hypertension

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Terlipressin availability varies
  • TIPS expertise required
  • Child-Pugh score affects outcomes
  • Requires multidisciplinary approach

Applicable Regions

USEU
Version 1Next review: 2027-01-11

Frequently Asked Questions

What is the Acute Variceal Hemorrhage Management (Baveno VII 2022)?

The Acute Variceal Hemorrhage Management (Baveno VII 2022) is a emergency clinical algorithm for Hepatobiliary Surgery. It provides a structured decision tree to guide clinical decision-making, based on Baveno VII Consensus for Portal Hypertension.

What guideline is the Acute Variceal Hemorrhage Management (Baveno VII 2022) based on?

This algorithm is based on Baveno VII Consensus for Portal Hypertension (DOI: 10.1016/j.jhep.2021.12.003).

What are the limitations of the Acute Variceal Hemorrhage Management (Baveno VII 2022)?

Known limitations include: Terlipressin availability varies; TIPS expertise required; Child-Pugh score affects outcomes; Requires multidisciplinary approach. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Acute Variceal Hemorrhage Management (Baveno VII 2022) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free